相似文献
1
Viral infection after renal transplantation: surveillance and management.
Clin J Am Soc Nephrol. 2008 Mar;3 Suppl 2(Suppl 2):S76-86. doi: 10.2215/CJN.02900707.
2
Viral infection in renal transplant recipients.
ScientificWorldJournal. 2012;2012:820621. doi: 10.1100/2012/820621. Epub 2012 May 2.
3
[Effects of viral infection on transplant recipients].
Enferm Infecc Microbiol Clin. 2007 Oct;25(8):535-48. doi: 10.1157/13109990.
4
Monitoring and managing viral infections in pediatric renal transplant recipients.
Pediatr Nephrol. 2012 May;27(5):705-17. doi: 10.1007/s00467-011-1812-2. Epub 2011 Feb 26.
5
Emerging viruses in transplantation: there is more to infection after transplant than CMV and EBV.
Transplantation. 2008 Nov 27;86(10):1327-39. doi: 10.1097/TP.0b013e31818b6548.
6
Viral infections in immunocompromised patients: what's new with respiratory viruses?
Curr Opin Infect Dis. 2002 Aug;15(4):355-67. doi: 10.1097/00001432-200208000-00002.
7
Emerging viral infections in transplantation.
Pediatr Transplant. 2006 Nov;10(7):838-43. doi: 10.1111/j.1399-3046.2005.00481.x.
8
Viral infections after renal transplantation.
Am J Kidney Dis. 2001 Apr;37(4):659-76. doi: 10.1016/s0272-6386(01)80114-1.
9
Common infections in kidney transplant recipients.
Clin J Am Soc Nephrol. 2012 Dec;7(12):2058-70. doi: 10.2215/CJN.04410512. Epub 2012 Sep 13.
10
Antiviral therapy in patients with hematologic malignancies, transplantation, and aplastic anemia.
Semin Hematol. 2009 Jul;46(3):230-47. doi: 10.1053/j.seminhematol.2009.03.004.
引用本文的文献
1
Thrombocytopenia following kidney transplantation: a frequent, underestimated and potentially severe complication.
Front Immunol. 2025 Mar 3;16:1519256. doi: 10.3389/fimmu.2025.1519256. eCollection 2025.
2
Valacyclovir for the prevention of cytomegalovirus infection after kidney transplantation.
BMC Infect Dis. 2025 Mar 5;25(1):314. doi: 10.1186/s12879-025-10671-6.
3
Longitudinal study of human polyomaviruses viruria in kidney transplant recipients.
Clin Exp Med. 2024 Jan 17;24(1):3. doi: 10.1007/s10238-023-01290-z.
4
Pre-Existing Intrarenal Parvovirus B19 Infection May Relate to Antibody-Mediated Rejection in Pediatric Kidney Transplant Patients.
Int J Mol Sci. 2023 May 23;24(11):9147. doi: 10.3390/ijms24119147.
5
Kidney Transplant-Associated Viral Infection Rates and Outcomes in a Single-Centre Cohort.
Viruses. 2022 Oct 29;14(11):2406. doi: 10.3390/v14112406.
6
Influenza and pneumococcal vaccination and COVID-19 in kidney transplant patients.
Transpl Immunol. 2022 Dec;75:101693. doi: 10.1016/j.trim.2022.101693. Epub 2022 Aug 11.
7
Risk of human papillomavirus infection and cervical intraepithelial lesions in Chinese renal transplant recipients.
Front Oncol. 2022 Jul 25;12:905548. doi: 10.3389/fonc.2022.905548. eCollection 2022.
8
Coronavirus Disease 2019 Positivity Immediately After Lung Transplantation: A Case Report.
Transplant Proc. 2022 Jul-Aug;54(6):1572-1574. doi: 10.1016/j.transproceed.2022.03.032. Epub 2022 Apr 22.
9
Pearls and Pitfalls in Pediatric Kidney Transplantation After 5 Decades.
Front Pediatr. 2022 Apr 8;10:856630. doi: 10.3389/fped.2022.856630. eCollection 2022.
10
Integrated cell-free DNA and cytokine analysis uncovers distinct tissue injury and immune response patterns in solid organ transplant recipients with COVID-19.
Res Sq. 2022 Jan 20:rs.3.rs-1262270. doi: 10.21203/rs.3.rs-1262270/v1.
本文引用的文献
1
Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients.
Am J Transplant. 2007 Sep;7(9):2106-13. doi: 10.1111/j.1600-6143.2007.01910.x. Epub 2007 Jul 19.
2
Prophylaxis and treatment of cytomegalovirus disease in recipients of solid organ transplants: current approach and future challenges.
Curr Opin Infect Dis. 2007 Aug;20(4):419-24. doi: 10.1097/QCO.0b013e32821f6026.
3
Late-onset acute haemorrhagic necrotizing granulomatous adenovirus tubulointerstitial nephritis in a renal allograft.
Nephrol Dial Transplant. 2007 Apr;22(4):1257-60. doi: 10.1093/ndt/gfl843. Epub 2007 Jan 31.
4
Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Clin Transplant. 2006 Nov-Dec;20(6):677-83. doi: 10.1111/j.1399-0012.2006.00534.x.
5
Retransplantation after post-transplant lymphoproliferative disorders: an OPTN/UNOS database analysis.
Am J Transplant. 2006 Nov;6(11):2743-9. doi: 10.1111/j.1600-6143.2006.01543.x.
6
Preventing post-organ transplantation cytomegalovirus disease with ganciclovir: a meta-analysis comparing prophylactic and preemptive therapies.
Clin Infect Dis. 2006 Oct 1;43(7):869-80. doi: 10.1086/507337. Epub 2006 Aug 23.
7
CMV-IVIG for prevention of Epstein Barr virus disease and posttransplant lymphoproliferative disease in pediatric liver transplant recipients.
Am J Transplant. 2006 Aug;6(8):1906-12. doi: 10.1111/j.1600-6143.2006.01394.x.
8
The natural course of cytomegalovirus infection and disease in renal transplant recipients.
Transplantation. 2006 Jul 27;82(2 Suppl):S15-7. doi: 10.1097/01.tp.0000230460.42558.b0.
9
Adenovirus infections in transplant recipients.
Clin Infect Dis. 2006 Aug 1;43(3):331-9. doi: 10.1086/505498. Epub 2006 Jun 19.
10
HIV-positive renal recipients can achieve survival rates similar to those of HIV-negative patients.
Transplantation. 2006 Jun 27;81(12):1658-61. doi: 10.1097/01.tp.0000226074.97314.e0.
Zotero 插件